UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000016009
Receipt No. R000018605
Official scientific title of the study The study of the efficiency of Keishibukuryogankayokuinin on acne vulgaris.
Date of disclosure of the study information 2014/12/19
Last modified on 2016/11/01 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The study of the efficiency of
Keishibukuryogankayokuinin on acne
vulgaris.
Title of the study (Brief title) The study of the efficiency of
Keishibukuryogankayokuinin on acne
vulgaris.
Region
Japan

Condition
Condition Acne vulgaris
Classification by specialty
Dermatology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate efficiency of Keishibukuryogankayokuinin in acne patients.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The decrement of inflammatory of acne lesions
The decrement of non-inflammatory of acne lesions
Patients QOL(SKINDEX-16,Syndromes presenting indefinite complaints)
Patients satisfaction(Visual analog scale)

Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 The treatment with medicine for external use with Oral Administration of keishibukuryogankayokuinin(2.5g t.i.d before meals)for 12 weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1)Patients who have inflammatory of acne lesions more than 6 counts on one side of their faces.
2)Patients for whom oral administration was possible.
3)Patients who agreed with their written informed consent
Key exclusion criteria 1)Patients with serious complications (liver,kidney,heart,blood,or metabolic disorders)
2)Steroid acne,Drug-induced acne,
Necrotizing acne, Occupational acne.
3)Patients who administrated steroid drugs on their whole body.
4)Women who are pregnant, might be pregnamt or lactating or planning a pregnancy.
5)Patients who received drugs prohibited for concomitant use within 1 week before the registration of this study.
6)Patients who participated in clinical trial within 1 month before the registration of this study.
7)Patients taking or planning chemical treatment or laser treatment in this study period.
8)Patients with history of hypersensitivity to traditional Japanese medicine.
9)Patients considered inappropriate by the study investigator
Target sample size 20

Research contact person
Name of lead principal investigator Toshitatsu Nogita
Organization Shinjuku Minamiguchi Dermatology Skin Clinic
Division name Director
Address 1-18-7 Nishishinjyuku Shinjyuku-ku Tokyo, Japan
TEL 03-3343-4103
Email nogita@hifuka.com

Public contact
Name of contact person Toshitatsu Nogita
Organization Shinjuku Minamiguchi Dermatology Skin Clinic
Division name Director
Address 1-18-7 Nishishinjyuku Shinjyuku-ku Tokyo, Japan
TEL 03-3343-4103
Homepage URL
Email nogita@hifuka.com

Sponsor
Institute Shinjuku Minamiguchi Dermatology Skin Clinic
Institute
Department

Funding Source
Organization TSUMURA & CO.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 12 Month 19 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 11 Month 21 Day
Anticipated trial start date
2015 Year 01 Month 05 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 12 Month 19 Day
Last modified on
2016 Year 11 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018605